Nysha Recent News

Health News

Major Lung Cancer Immunotherapy Progress Reported at Conference, in Study


Chicago, IL — According to the American Cancer Society, about 234,030 new cases of lung cancer will be diagnosed in the U.S. in 2018, and about 154,050 Americans will die from it.


But thanks to heartening news from several studies presented recently at the annual American Association for Cancer Research (AACR) conference in Chicago, it seems that the latest advances in immunotherapy may be able to extend or even save the lives of many of them.


Immunotherapy, a relatively still-new discipline, involves harnessing the body’s immune system to seek out, attack and destroy targeted cancer cells.


At the conference, several studies were presented showing significant benefits of combining various new immunotherapy drugs with existing cancer treatments like chemotherapy.


One study found that pre-treating lung cancer patients with immune therapy drugs before they have surgery can help melt away the tumor and at the same time limit or even stop its spread.


Also, combinations of certain immunotherapy drugs were found to help other lung cancer patients get off more toxic standard chemotherapy while also extending their lives.


However, these front-line new immunotherapy drugs can cost over $100,000 for a single course of treatment.